Form 4: BVF Partners Converts XOMA Preferred Stock to Common

BVF Partners and affiliated entities converted 4,993,000 shares of Series X Convertible Preferred Stock into Common Stock of XOMA Royalty Corp.

Summary

• BVF Partners L.P. and its affiliates converted a total of 4,993,000 shares of Series X Convertible Preferred Stock into an equal number of shares of Common Stock.
• The conversion occurred on May 14, 2026, at a conversion price of $4.03 per share.
• The transaction involved multiple entities under the BVF umbrella, including Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., and Biotechnology Value Trading Fund OS LP.
• Following the conversion, the reporting persons maintain their status as 10% owners of XOMA Royalty Corp.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine internal capital structure adjustment by a major shareholder rather than a change in the company's fundamental business outlook.

Positives

• Conversion of preferred stock into common stock simplifies the capital structure of the issuer.
• The conversion reflects continued long-term investment commitment from a major institutional shareholder.

Negatives

• The conversion increases the number of outstanding common shares, which may lead to minor dilution for existing shareholders.

Risks

• Concentration of ownership by BVF Partners may influence corporate decision-making.
• Market liquidity and price volatility could be impacted by the increased float of common stock.

Future Outlook

No specific forward-looking guidance regarding company operations was provided; the filing is strictly a disclosure of changes in beneficial ownership.

Management Comments

• The reporting persons disclaim beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.

Industry Context

StockSavvy.ai notes that institutional investors in the biotech royalty space frequently utilize convertible preferred structures to manage risk and maintain flexibility in their capital allocation strategies.

Comparison to Industry Standards

• The conversion of preferred equity to common stock is a standard corporate governance event for companies with complex capital structures.
• BVF Partners' activity is consistent with typical institutional portfolio rebalancing within the life sciences sector.

Stakeholder Impact

• Shareholders may experience minor dilution due to the increase in common stock outstanding.
• The conversion provides greater transparency regarding the equity position of the largest shareholders.

Next Steps

• Continued monitoring of SEC filings for further changes in beneficial ownership by major shareholders.

Key Dates

Keywords

XOMA, BVF Partners, Convertible Preferred Stock, SEC Form 4, Insider Ownership, Equity Conversion